Analysis of the autonomic nervous system before and after treatment for postherpetic neuralgia
Not Applicable
- Conditions
- postherpetic neuralgia
- Registration Number
- JPRN-UMIN000053530
- Lead Sponsor
- Faculty of Medicine, Kindai University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) AST (GOT) or ALT (GPT) > 100 IU/L 2) Child-Pugh classification B or C 3) Serum creatinine greater than 2.0 mg/dL 4) Patients with a cardiac pacemaker or ICD 5) Patients with a clinical history of ischemic heart disease, arrhythmia, respiratory disease, infectious disease, metabolic disease, or autoimmune disease 6) Patients who have expressed their refusal (including verbal refusal) to this study 7) Patients who are deemed inappropriate by the principal investigator 8) Patients who are taking autonomic nerve-acting drugs, anti-arrhythmic drugs, or benzodiazepines
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of pre-treatment - post-treatment heart rate variability (HF, LF/HF) in the pulsed radiofrequency treatment effective group
- Secondary Outcome Measures
Name Time Method